跳至主要内容
临床试验/NCT05291598
NCT05291598已完成3 期

IV Meloxicam for Pain Management Post TJA: Prospective Randomized Trial

University of Miami1 个研究点 分布在 1 个国家目标入组 223 人开始时间: 2022年5月1日最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
223
试验地点
1
主要终点
Pain Measured by the Numeric Rating Scale

研究概览

简要总结

The purpose of this project is to determine if a change in patient reported pain, nausea and vomiting after total knee and hip arthroplasty could be observed with the substitution of Intravenous meloxicam for ketorolac in the current established peri-operative pain protocol and if these changes lead to a decrease in opioid consumption (in morphine equivalents).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients over the age of 18,
  • Patients undergoing primary total knee or primary total hip replacement at the University of Miami Hospital,
  • Patients that have capacity to provide medical consent

排除标准

  • All patients under the age of 18
  • Prisoners, diabetics, increased risk of bleeding, and pregnant women.
  • Patients with prior surgery or history of infection on the joint of interest.
  • Patients with an estimated glomerular filtration rate (eGFR) <50 ml/min
  • Patients on dialysis or renal transplant.
  • Patients on steroid preoperatively.
  • Allergy to sulfas
  • Inability to provide medical consent.
  • Any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements will exclude the participant.

研究组 & 干预措施

Ketorolac group

Active Comparator

Participants will receive the institution specific joint replacement pain protocol, including ketorolac.

干预措施: Ketorolac (Drug)

IV meloxicam group

Experimental

Participants will receive the institution specific joint replacement pain protocol, however with IV meloxicam substituted for ketorolac.

干预措施: IV meloxicam (Drug)

结局指标

主要结局

Pain Measured by the Numeric Rating Scale

时间窗: 24 hours postoperatively

A numeric pain rating scale will be used - a higher pain score would indicate higher pain levels. It is scaled 0-10.

次要结局

  • Length of Stay as Measured by Same Day Discharges(From surgery until discharge)
  • Opioid Consumption as Measured by Morphine Milligram Equivalents (MME)(Within 24 hours postoperatively)
  • Renal Injury as Measured by the Change in Creatinine Levels(From preoperative baseline labs while hospitalized, up to 1 week)
  • Nausea Score as Measured by a Likert Scale(24 hours postoperatively)
  • Length of Stay as Measured by Hospital Nights(From surgery until discharge)
  • Length of Stay as Measured by Hours in the Hospital(Until patient discharged from the hospital)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Victor Hugo Hernandez

Professor Chief - Division of Arthroplasty & Adult Reconstruction, Department of Orthopaedics

University of Miami

研究点 (1)

Loading locations...

相似试验